Home > Cashflow Statement > CORONA REMEDIES

CORONA REMEDIES
Cash Flow from Operating Activities

    Back to Cashflow Statement
CORONA REMEDIES is part of below Screeners ↓
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for CORONA REMEDIES
Please provide your vote to see the results

CORONA REMEDIES Last 5 Year Cash Flow from Operating Activities History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023
Cash Flow from Operating Activities ₹229 Cr₹190 Cr₹157 Cr₹103 Cr

What is the latest Cash Flow from Operating Activities ratio of CORONA REMEDIES ?

The latest Cash Flow from Operating Activities ratio of CORONA REMEDIES is ₹229 Cr based on Mar2026 Consolidated results.
Year Cash Flow from Operating Activities
Mar2026₹229 Cr
Mar2025₹190 Cr
Mar2024₹157 Cr
Mar2023₹103 Cr

How is Cash Flow from Operating Activities of CORONA REMEDIES Trending?

Years Cash Flow from Operating Activities % Change
Mar2026 ₹229 Cr
20.47
Mar2025 ₹190 Cr
21.52
Mar2024 ₹157 Cr
52.64
Mar2023 ₹103 Cr -

Compare Cash Flow from Operating Activities of peers of CORONA REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
CORONA REMEDIES ₹12,054.9 Cr 6.6% 17.6% NA Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹449,299.0 Cr 0.5% 1.5% 11.9% Stock Analytics
DIVIS LABORATORIES ₹174,207.0 Cr -3.3% -3.5% 1.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹157,721.0 Cr 4.5% 2.6% 42.6% Stock Analytics
CIPLA ₹117,420.0 Cr 2.7% 2.5% -4% Stock Analytics
DR REDDYS LABORATORIES ₹114,876.0 Cr 6.6% 4.3% 1.9% Stock Analytics


CORONA REMEDIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
CORONA REMEDIES

6.6%

17.6%

NA
SENSEX

-0.1%

1%

-5.7%


You may also like the below Video Courses